Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wright gets US nod for Allomatrix line:

This article was originally published in Clinica

Executive Summary

Orthopaedic medical device company Wright Medical has gained US market clearance for its Allomatrix family of allograft bone void fillers. Following FDA clearance of its Allomatrix injectable putty in March this year, the company has now been given the go-ahead to sell its Allomatrix C, Allomatrix Custom, and Allomatrix DR bone graft putties that contain demineralised bone matrix (DBM) and specific volumes and configurations of donor matched, cancellous bone chips. The Arlington, Tennessee firm claims that its Allomatrix products and Osteoset 2 DBM bone graft substitute are the only commercially available, FDA-cleared products which contain DBM.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059142

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel